“…Practices for oxidative forced degradation are particularly subject to interpretation 3. Recently, there has been a resurgence of interest in evaluating how the meaningfulness and predictive power of oxidative forced degradation can be increased and improved 4, 5. A survey of industry practices in 2003 suggested a wide variety of oxidation conditions, including a growing trend of the use of azonitrile radical initiators such as AIBN (2, 2′‐azobisisobutyronitrile) and ACVA (4,4′‐azobis‐4‐cyanovaleric acid) to purposefully induce peroxy radical oxidation of drug substance in solution 2…”